<DOC>
	<DOCNO>NCT01022905</DOCNO>
	<brief_summary>The objective study assess vaccine response novel adjuvanted influenza A ( H1N1 ) vaccines patient high risk influenza A ( H1N1 ) complication .</brief_summary>
	<brief_title>Vaccine Responses Influenza A H1N1/09 Immunization High-risk Patients</brief_title>
	<detailed_description>This prospective , open-label , parallel-cohorts study include 1250 patient 250 control influenza A ( H1N1 ) immunization recommend . Six cohort establish , enrol patient HIV infection , rheumatic disease , organ transplant , cancer , pediatric patient healthy control . Subjects assess specific antibody response ( ) , T cell response ( subset ) solicit vaccine adverse event . Vaccine safety evaluation include influence immunization underlie disease ( HIV infect patient , patient auto-immune disease ) graft function ( transplant patient ) - appropriate .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>medically recommend influenza A ( H1N1 ) immunization sign informed consent failure refusal provide sufficient blood antibody determination</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>HIV infection</keyword>
	<keyword>transplant</keyword>
	<keyword>rheumatic disease</keyword>
	<keyword>cancer</keyword>
	<keyword>child</keyword>
</DOC>